Therapeutics: Histone methyltransferase DOT1L (DOT1L); bromodomain containing 4 (BRD4)

Cancer

INDICATION: Leukemia

Cell culture studies suggest combining inhibitors of DOT1L and BRD4 could help treat mixed lineage leukemia (MLL).

Read the full 189 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE